{"id":"W2285484581","doi":"10.1177/1756287215621471","title":"Degarelix monotherapy compared with luteinizing hormone-releasing hormone (LHRH) agonists plus anti-androgen flare protection in advanced prostate cancer: an analysis of two randomized controlled trials","year":2015,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Hazard ratio; Urology; Internal medicine; Proportional hazards model; Bicalutamide; Hormone antagonist; Luteinizing hormone; Goserelin; Population; Agonist; Antiandrogen; Oncology; Gynecology; Confidence interval; Cancer; Hormone; Endocrine system; Androgen receptor; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01922015,0.001821132,0.009976776,0.001563775,0.0005074544,0.002358313,0.001364166,0.002693887,0.002849461],"category_scores_gemma":[0.02166479,0.001050398,0.01225687,0.001595969,0.001236768,0.00171156,0.0006578856,0.002198252,0.0002205443],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001256337,"about_ca_system_score_gemma":0.001438774,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007625376,"about_ca_topic_score_gemma":0.00124867,"domain_scores_codex":[0.9824086,0.01250583,0.001918047,0.00143872,0.001272738,0.0004559946],"domain_scores_gemma":[0.9778284,0.01433786,0.005016468,0.001145616,0.0007852489,0.0008863523],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9146951,0.00134907,0.002705654,0.005357045,0.0578827,0.00007379954,0.00005468022,0.0004163519,0.0009581455,0.0001196871,0.0002226229,0.01616508],"study_design_scores_gemma":[0.8732443,0.05373893,0.009078261,0.0006191357,0.06058187,0.00008970697,0.00005570861,0.001200927,0.0003622373,0.000318068,0.000660716,0.00005008984],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8106604,0.1763736,0.003719669,0.0008640679,0.001320551,0.004997299,0.0008774602,0.0001426199,0.001044465],"genre_scores_gemma":[0.9674658,0.02390477,0.002752423,0.0008587663,0.0007864329,0.003036398,0.000585688,0.00003073542,0.0005791158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01922015,"threshold_uncertainty_score":0.1016471,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0447651738103733,"score_gpt":0.3583759912898923,"score_spread":0.313610817479519,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}